ID
12467
Beschreibung
The aim of the Mashed Or Just Integral pill of TicagrelOr (MOJITO) study is to evaluate the superiority of Ticagrelor 180 mg LD mashed pill versus Ticagrelor 180 mg LD integral pill both orally administrated in decreasing residual platelet reactivity 1 hour after the administration among 70 patients with STEMI (ST segment elevation myocardial infarction) undergoing PPCI (primary percutaneous coronary intervention) with bivalirudin monotherapy. https://clinicaltrials.gov/ct2/show/NCT01992523
Link
https://clinicaltrials.gov/ct2/show/NCT01992523
Stichworte
Versionen (2)
- 28.07.15 28.07.15 -
- 21.11.15 21.11.15 -
Hochgeladen am
21. November 2015
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Mojito Study Acute Coronary Syndrome NCT01992523
Eligibility Criteria
- StudyEvent: ODM
Beschreibung
Exclusion Criteria
Beschreibung
Age < 18 years or Age > 75 years
Datentyp
boolean
Alias
- UMLS CUI-1
- C0001779
Beschreibung
Active bleeding
Datentyp
boolean
Alias
- UMLS CUI-1
- C0019080
Beschreibung
bleeding diathesis
Datentyp
boolean
Alias
- UMLS CUI-1
- C3251812
Beschreibung
coagulopathy
Datentyp
boolean
Alias
- UMLS CUI-1
- C0005779
Beschreibung
Increased risk of bradycardiac events
Datentyp
boolean
Alias
- UMLS CUI-1
- C0428977
Beschreibung
History of gastrointestinal bleeding <2 months
Datentyp
boolean
Alias
- UMLS CUI-1
- C0017181
Beschreibung
History of genitourinary bleeding <2 months
Datentyp
boolean
Alias
- UMLS CUI-1
- C0919591
Beschreibung
Major surgery in the last 6 weeks
Datentyp
boolean
Alias
- UMLS CUI-1
- C0679637
Beschreibung
History of intracranial bleeding or structural abnormalities
Datentyp
boolean
Alias
- UMLS CUI-1
- C0151699
Beschreibung
Suspected aortic dissection
Datentyp
boolean
Alias
- UMLS CUI-1
- C0340643
Beschreibung
Administration in the week before the index event of clopidogrel
Datentyp
boolean
Alias
- UMLS CUI-1
- C0070166
Beschreibung
Administration in the week before the index event of ticlopidine
Datentyp
boolean
Alias
- UMLS CUI-1
- C0040207
Beschreibung
Administration in the week before the index event of prasugrel
Datentyp
boolean
Alias
- UMLS CUI-1
- C1620287
Beschreibung
Administration in the week before the index event of ticagrelor
Datentyp
boolean
Alias
- UMLS CUI-1
- C1999375
Beschreibung
Administration in the week before the index event of thrombolytics
Datentyp
boolean
Alias
- UMLS CUI-1
- C0040044
Beschreibung
Administration in the week before the index event of bivalirudin
Datentyp
boolean
Alias
- UMLS CUI-1
- C0168273
Beschreibung
Administration in the week before the index event of low-molecular weight heparin
Datentyp
boolean
Alias
- UMLS CUI-1
- C3536766
Beschreibung
Administration in the week before the index event of fondaparinux
Datentyp
boolean
Alias
- UMLS CUI-1
- C1098510
Beschreibung
Concomitant oral or IV therapy with strong CYP3A inhibitors
Datentyp
boolean
Alias
- UMLS CUI-1
- C3830624
Beschreibung
Concomitant oral or IV therapy with strong CYP3A inducers
Datentyp
boolean
Alias
- UMLS CUI-1
- C3830625
Beschreibung
Known relevant hematological deviations: Hb <10 g/dl
Datentyp
boolean
Alias
- UMLS CUI-1
- C0518015
Beschreibung
Known relevant hematological deviations: Thrombi. <100x10^9/l
Datentyp
boolean
Alias
- UMLS CUI-1
- C0032181
Beschreibung
Use of coumadin derivatives within the last 7 days
Datentyp
boolean
Alias
- UMLS CUI-1
- C0043031
Beschreibung
Known severe liver disease
Datentyp
boolean
Alias
- UMLS CUI-1
- C0085605
Beschreibung
severe renal failure
Datentyp
boolean
Alias
- UMLS CUI-1
- C0035078
Beschreibung
Known allergy to the study medications
Datentyp
boolean
Alias
- UMLS CUI-1
- C0013182
Beschreibung
Pregnancy
Datentyp
boolean
Alias
- UMLS CUI-1
- C0549206
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: ODM